Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF022
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,687
Award facts
- Contract value 100% obligated
- $13,686.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 29, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $13,686.71 to AmerisourceBergen Drug Corp for the supply of Cosentyx Unoready 300 mg pen 2ml, a pharmaceutical product used in the treatment of autoimmune conditions. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, will be fulfilled by AmerisourceBergen's Corporate Office division located in Conshohocken, Pennsylvania, with an ultimate completion date of January 30, 2026. The delivery order operates under AmerisourceBergen's parent company Cencora, Inc., which holds a significant indefinite delivery contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 31, 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare programs globally.
This award reflects AmerisourceBergen's established role as a critical vendor within the federal pharmaceutical supply chain, particularly for military and veteran healthcare systems. As a major pharmaceutical distributor, the company routinely fulfills delivery orders for a diverse portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The DLA Troop Support Medical IDC under which this delivery order falls encompasses comprehensive global pharmaceutical support, enabling the company to supply essential medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FF022?
SPE2DR26FF022 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FF022 worth?
The government has obligated $13,687 on SPE2DR26FF022.
Is contract SPE2DR26FF022 an order under another contract?
Yes. SPE2DR26FF022 is a delivery order under SPE2DR25D1103, an indefinite delivery contract.
Was contract SPE2DR26FF022 competed?
The extent of competition for SPE2DR26FF022 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award